 | Up a level |
Wykoff, Charles C; Garweg, Justus G; Regillo, Carl; Souied, Eric; Wolf, Sebastian; Dhoot, Dilsher S; Agostini, Hansjuergen T; Chang, Andrew; Laude, Augustinus; Wachtlin, Joachim; Kovacic, Lidija; Wang, Lixin; Wang, Ying; Bouillaud, Emmanuel; Brown, David M (2024). KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients with diabetic macular edema. American journal of ophthalmology, 260, pp. 70-83. Elsevier Science 10.1016/j.ajo.2023.07.012
Maestre, Fernando T; Le Bagousse-Pinguet, Yoann; Delgado-Baquerizo, Manuel; Eldridge, David J; Saiz, Hugo; Berdugo, Miguel; Gozalo, Beatriz; Ochoa, Victoria; Guirado, Emilio; García-Gómez, Miguel; Valencia, Enrique; Gaitán, Juan J; Asensio, Sergio; Mendoza, Betty J; Plaza, César; Díaz-Martínez, Paloma; Rey, Ana; Hu, Hang-Wei; He, Ji-Zheng; Wang, Jun-Tao; ... (2022). Grazing and ecosystem service delivery in global drylands. Science, 378(6622), pp. 915-920. American Association for the Advancement of Science 10.1126/science.abq4062
Brown, David M; Emanuelli, Andrés; Bandello, Francesco; Barranco, Jose Juan Escobar; Figueira, João; Souied, Eric; Wolf, Sebastian; Gupta, Vishali; Ngah, Nor Fariza; Liew, Gerald; Tuli, Raman; Tadayoni, Ramin; Dhoot, Dilsher; Wang, Lixin; Bouillaud, Emmanuel; Wang, Ying; Kovacic, Lidija; Guerard, Nicolas; Garweg, Justus (2022). KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema. American journal of ophthalmology, 238, pp. 157-172. Elsevier 10.1016/j.ajo.2022.01.004
